Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1976 of 6351
-
AI-Powered therapy shows promise in curbing teen violence
Disease control CompletedThis study will use a randomized control trial (RCT) design to administer two versions of a multisession remote behavioral intervention for youth seeking Emergency Department care for a violent injury with the goal to reduce their violence involvement and associated negative beha…
Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Spine fracture fix: new device aims to ease back pain
Disease control OngoingThis study is a prospective, single-arm, multi-center, European clinical study designed to evaluate the clinical performance and safety of the AGN1 LOEP SV Kit for the treatment of painful VCFs.
Sponsor: AgNovos Healthcare, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Heart-Saving hope for neuroendocrine cancer patients
Disease control OngoingThis phase III trial compares the effect of telotristat ethyl and the current standard of care somatostatin analog therapy or somatostatin analog therapy alone in treating patients with neuroendocrine tumor that has spread to other places in the body (metastatic). Telotristat eth…
Phase 3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Radiation before breast surgery may improve results
Disease control OngoingThis phase II trial investigates the safety of delivering a part (boost) of radiation treatment before breast surgery in treating patients with breast cancer that has not spread to other places in the body (non-metastatic). Radiation therapy uses high energy photons/electrons to …
Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental combo targets Hard-to-Treat stomach cancer
Disease control CompletedThis clinical study is a Phase 2, open-label study to assess the efficacy, safety profile of FLX475 combined with pembrolizumab in patients with advanced or metastatic gastric cancer. This study is designed to assess the potential anti-tumor activity when administered at the 100m…
Phase 2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Salt's secret role: could your immune system be driving blood pressure?
Knowledge-focused CompletedSalt sensitivity of blood pressure (SSBP) is defined as the change in blood pressure (BP) in relation to change in salt intake. An increase in BP from low- to high-salt diet is common and associated with an increased risk of cardiovascular morbidity and mortality, even among norm…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Gene therapy shot may ease diabetic foot pain for a year
Symptom relief CompletedTo evaluate the durability of efficacy and long-term safety of intramuscular administration of Engensis or Placebo that was administered in the double-blind, randomized, VMDN-003-2 Placebo-controlled Phase 3 Study.
Phase 3 • Sponsor: Helixmith Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can your voice reveal early dementia? new study tests AI speech analysis
Diagnosis CompletedDementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient wil…
Sponsor: Accexible • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Zapping the brain to kick the habit: new trial tests rTMS for smoking cessation
Symptom relief Recruiting nowCigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smoker…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Could an eye implant stop glaucoma from stealing your sight?
Disease control OngoingTo determine the safety and efficacy over 24 months of dual NT-501 CNTF encapsulated cell therapy (ECT) on visual impairment related to glaucoma.
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug shows promise for rare stomach disease
Disease control Completed40 participants with Eosinophilic Gastritis 12-70 years of age will be randomly assigned with dupilumab or placebo subcutaneous injections every two weeks for a total of 12 weeks. Study subjects who complete the 12-week treatment phase, may continue into an open label extension s…
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Combination therapy shows promise in reversing frailty in older veterans
Disease control CompletedThe continuing increase in prevalence of obesity in older adults including many older Veterans has become a major health concern. The clinical trial will test the central hypothesis that a multicomponent intervention consisting of lifestyle therapy (diet-induced weight loss and e…
Phase 3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a psoriasis drug stop transplant rejection?
Disease control OngoingThis phase II trial studies how well ustekinumab works in preventing acute graft-versus-host disease after unrelated donor hematopoietic cell transplant. Sometimes the transplanted cells from a donor can attack the body's normal tissues (called graft-versus-host disease). Giving …
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for hard-to-treat melanoma: drug combo targets NRAS mutation
Disease control OngoingThis study will evaluate the safety, pharmacokinetics, and activity of belvarafenib as a single agent and in combination with either cobimetinib or cobimetinib plus nivolumab in patients with NRAS-mutant advanced melanoma who have received anti-PD-1/PD-L1 therapy.
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Seaweed supplement could boost sperm quality in infertile men
Disease control CompletedTetraSOD® is a unique marine phytoplankton (Tetraselmis chuii) SOD-rich ingredient that is grown under patent-protected technology exclusively designed by the company Fitoplancton Marino, S.L. (Spain). In a previous pilot trial, the ability of TetraSOD® to improve semen character…
Sponsor: Fitoplancton Marino, S.L. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a pill replace needles for acromegaly?
Disease control Stopped earlyA randomized, placebo-controlled study designed to evaluate the safety and efficacy of paltusotine (also known as CRN00808; an orally administered nonpeptide somatostatin agonist) in subjects with acromegaly previously treated with somatostatin receptor ligand (SRL) based treatme…
Phase 3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New stomach drug could shield heart patients from bleeding
Disease control Recruiting nowThe primary aim of this study is to evaluate the efficacy and safety of novel P-CAB (tegoprazan 50 mg once daily) as compared with standard PPI (rabeprazole 20 mg once daily) for protection of GI events in patients with known cardiac and vascular disease receiving chronic use of …
Phase 4 • Sponsor: Duk-Woo Park, MD • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Home monitoring may keep cancer patients out of the ER
Symptom relief OngoingThis clinical trial studies if enhanced outpatient symptom management with telemedicine and remote monitoring can help reduce acute care visit due to chemotherapy-related adverse events. Receiving telemedicine and remote monitoring may help patients have better outcomes (such as …
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to overcome resistance in lung cancer treatment
Disease control CompletedThe current study focuses on unresectable stage III non-small cell lung cancer (NSCLC) patients who are starting Durvalumab consolidation after concurrent chemoradiation with a goal of cure. The overall hypothesis of this study is that the addition of Copanlisib to Durvalumab wil…
Phase 1 • Sponsor: Zhonglin Hao • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New Double-Action antibody shows promise against Hard-to-Treat cancers
Disease control CompletedThis is a multi-center phase II clinical trial to evaluate the anti-tumor activity and safety of HX009 in subjects with advanced solid tumors.
Phase 2 • Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC